Powder and solvent for suspension for Intravesical use.
After reconstitution, one vial contains BCG (Bacillus Calmette-Guérin) bacteria seed RIVM derived from seed 1173-P2, 2 x 108 to 3 x 109 viable units.
Indicated for Treatment of non-invasive urothelial bladder carcinoma:
BCG-medac Kit contains:
Powder and solvent for intravesical solution 10mg, 20m and 40mg
Mitomycin medac is indicated as intravesical administration for relapse prevention in adult patients with superficial urinary bladder carcinoma after transurethral resection.
Mitomycin medac kit contains: